Fig 1From: Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reportsThe clinical course of two cases under BLIN + ponatinib combination therapy. The clinical courses of cases 1 and 2 are shown in a, b, respectively. In each chart, the vertical axis and horizontal axis show the amount of BCR–ABL (%) and the time point, respectively. VCR vincristine, dex dexamethasone, C cycle, CRS cytokine release syndrome, Gr gradeBack to article page